Amedeo Smart

Free Medical Literature Service


 

Amedeo

HIV Infection

  Free Subscription

Articles published in
HIV Med
    November 2017
  1. YOUNG J, Smith C, Teira R, Reiss P, et al
    Antiretroviral pill count and clinical outcomes in treatment-naive patients with HIV infection.
    HIV Med. 2017 Nov 6. doi: 10.1111/hiv.12562.
    >> Share

  2. HUFF H, Merchant AT, Lonn E, Pullenayegum E, et al
    Vitamin D and progression of carotid intima-media thickness in HIV-positive Canadians.
    HIV Med. 2017 Nov 6. doi: 10.1111/hiv.12563.
    >> Share

  3. AIBIBULA W, Cox J, Hamelin AM, Moodie E, et al
    Food insecurity may lead to incomplete HIV viral suppression and less immune reconstitution among HIV/hepatitis C virus-coinfected people.
    HIV Med. 2017 Nov 2. doi: 10.1111/hiv.12561.
    >> Share


  4. A note of thanks to referees for Volume 18, 2017.
    HIV Med. 2017;18:793-795.
    >> Share

    October 2017
  5. DE WIT S, Battegay M, D'Arminio Monforte A, Lundgren JD, et al
    European AIDS Clinical Society Second Standard of Care Meeting, Brussels 16-17 November 2016: a summary.
    HIV Med. 2017 Oct 27. doi: 10.1111/hiv.12559.
    >> Share

  6. COZZI-LEPRI A, Zangerle R, Machala L, Zilmer K, et al
    Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens.
    HIV Med. 2017 Oct 6. doi: 10.1111/hiv.12557.
    >> Share

  7. FUREGATO M, Mitchell H, Ogaz D, Woodhall S, et al
    The role of frequent HIV testing in diagnosing HIV in men who have sex with men.
    HIV Med. 2017 Oct 6. doi: 10.1111/hiv.12558.
    >> Share

    September 2017
  8. GERETTI AM, Loutfy M, D'Arminio Monforte A, Latysheva I, et al
    Out of focus: tailoring the cascade of care to the needs of women living with HIV.
    HIV Med. 2017;18 Suppl 2:3-17.
    >> Share

    August 2017
  9. SHEPHERD L, Borges AH, Harvey R, Bower M, et al
    The extent of B-cell activation and dysfunction preceding lymphoma development in HIV-positive people.
    HIV Med. 2017 Aug 31. doi: 10.1111/hiv.12546.
    >> Share

  10. HOFFMANN C, Welz T, Sabranski M, Kolb M, et al
    Reply to Letter 'Morning dosing for dolutegravir-related insomnia and sleep disorders' by Capetti et al.
    HIV Med. 2017 Aug 29. doi: 10.1111/hiv.12539.
    >> Share

  11. DE POKOMANDY A, Rouleau D, Lalonde R, Beauvais C, et al
    Argon plasma coagulation treatment of anal high-grade squamous intraepithelial lesions in men who have sex with men living with HIV: results of a 2-year prospective pilot study.
    HIV Med. 2017 Aug 23. doi: 10.1111/hiv.12544.
    >> Share

  12. CUZIN L, Yazdanpanah Y, Huleux T, Cotte L, et al
    No relationship between late HIV diagnosis and social deprivation in newly diagnosed patients in France.
    HIV Med. 2017 Aug 18. doi: 10.1111/hiv.12545.
    >> Share

  13. KAMAL S, Bugnon O, Cavassini M, Schneider MP, et al
    HIV-infected patients' beliefs about their chronic co-treatments in comparison with their combined antiretroviral therapy.
    HIV Med. 2017 Aug 16. doi: 10.1111/hiv.12542.
    >> Share

  14. RAJASINGHAM R, Meya DB, Boulware DR
    Are fluconazole or sertraline dose adjustments necessary with concomitant rifampin?
    HIV Med. 2017 Aug 1. doi: 10.1111/hiv.12543.
    >> Share

  15. CAPETTI AF, Di Giambenedetto S, Latini A, Sterrantino G, et al
    Morning dosing for dolutegravir-related insomnia and sleep disorders.
    HIV Med. 2017 Aug 1. doi: 10.1111/hiv.12540.
    >> Share

  16. SOODLA P, Simmons R, Huik K, Pauskar M, et al
    HIV incidence in the Estonian population in 2013 determined using the HIV-1 limiting antigen avidity assay.
    HIV Med. 2017 Aug 1. doi: 10.1111/hiv.12535.
    >> Share

    July 2017
  17. ADETUNJI AA, Kuti MA, Audu RA, Muyibi SA, et al
    Discordant rapid HIV tests: lessons from a low-resource community.
    HIV Med. 2017 Jul 31. doi: 10.1111/hiv.12541.
    >> Share

  18. SCHEPER H, van Holten N, Hovens J, de Boer M, et al
    Severe depression as a neuropsychiatric side effect induced by dolutegravir.
    HIV Med. 2017 Jul 26. doi: 10.1111/hiv.12538.
    >> Share


  19. Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?
    HIV Med. 2017 Jul 25. doi: 10.1111/hiv.12536.
    >> Share

  20. GUARALDI G, Malagoli A, Theou O, Brothers TD, et al
    Correlates of frailty phenotype and frailty index and their associations with clinical outcomes.
    HIV Med. 2017 Jul 24. doi: 10.1111/hiv.12527.
    >> Share

  21. ORKIN C, Llibre JM, Gallien S, Antinori A, et al
    Nucleoside reverse transcriptase inhibitor-reducing strategies in HIV treatment: assessing the evidence.
    HIV Med. 2017 Jul 24. doi: 10.1111/hiv.12534.
    >> Share

  22. TIRABOSCHI J, Ray S, Patel K, Teague A, et al
    The impact of immunoglobulin in acute HIV infection on the HIV reservoir: a randomized controlled trial.
    HIV Med. 2017 Jul 18. doi: 10.1111/hiv.12524.
    >> Share

  23. PETT SL, Amin J, Horban A, Andrade-Villanueva J, et al
    Week 96 results of the randomized, multicentre Maraviroc Switch (MARCH) study.
    HIV Med. 2017 Jul 13. doi: 10.1111/hiv.12532.
    >> Share

  24. JABS AW, Jabs DA, Van Natta ML, Palella FJ, et al
    Insurance status and mortality among patients with AIDS.
    HIV Med. 2017 Jul 11. doi: 10.1111/hiv.12531.
    >> Share

  25. NANDAR K, Ang LW, Tey J, James L, et al
    Epidemiology of tuberculosis and HIV coinfections in Singapore, 2000-2014.
    HIV Med. 2017 Jul 4. doi: 10.1111/hiv.12529.
    >> Share

  26. ECHEVERRIA P, Bonjoch A, Puig J, Ornella A, et al
    Significant improvement in triglyceride levels after switching from ritonavir to cobicistat in suppressed HIV-1-infected subjects with dyslipidaemia.
    HIV Med. 2017 Jul 3. doi: 10.1111/hiv.12530.
    >> Share

  27. CUZIN L, Katlama C, Cotte L, Pugliese P, et al
    Ageing with HIV: do comorbidities and polymedication drive treatment optimization?
    HIV Med. 2017;18:395-401.
    >> Share

    June 2017
  28. WANG X, Nwokolo N, Korologou-Linden R, Hill A, et al
    InterPrEP: internet-based pre-exposure prophylaxis with generic tenofovir disoproxil fumarate/emtrictabine in London - analysis of pharmacokinetics, safety and outcomes.
    HIV Med. 2017 Jun 28. doi: 10.1111/hiv.12528.
    >> Share

  29. PROTIERE C, Preau M, Carrieri P, Lambotte O, et al
    Importance of the patient-physician interaction in assessing acceptability of HIV cure trials.
    HIV Med. 2017 Jun 20. doi: 10.1111/hiv.12526.
    >> Share

  30. IRELAND G, Ogaz D, Kirwan P, Mandal S, et al
    HIV testing in persons diagnosed with hepatitis B and C.
    HIV Med. 2017 Jun 14. doi: 10.1111/hiv.12525.
    >> Share

  31. SAPOZHNIKOV J, Young JD, Patel M, Chiampas TD, et al
    Prevalence of HIV-1 transmitted drug resistance in the incarcerated population.
    HIV Med. 2017 Jun 6. doi: 10.1111/hiv.12522.
    >> Share

    May 2017
  32. REEVES A, Steele S, Stuckler D, McKee M, et al
    Gender violence, poverty and HIV infection risk among persons engaged in the sex industry: cross-national analysis of the political economy of sex markets in 30 European and Central Asian countries.
    HIV Med. 2017 May 28. doi: 10.1111/hiv.12520.
    >> Share

  33. ORBAEK M, Thorsteinsson K, Helleberg M, Moseholm E, et al
    Assessment of mode of delivery and predictors of emergency caesarean section among women living with HIV in a matched-pair setting with women from the general population in Denmark, 2002-2014.
    HIV Med. 2017 May 24. doi: 10.1111/hiv.12519.
    >> Share

  34. HAMPEL B, Kusejko K, Braun DL, Harrison-Quintana J, et al
    Assessing the need for a pre-exposure prophylaxis programme using the social media app Grindr(R).
    HIV Med. 2017 May 19. doi: 10.1111/hiv.12521.
    >> Share

  35. RIGO F, Cucchetto G, Lanzafame M, Nicole S, et al
    Dual therapy with a combination of unboosted atazanavir and lamivudine as maintenance treatment in virologically suppressed HIV-1-infected patients.
    HIV Med. 2017 May 15. doi: 10.1111/hiv.12523.
    >> Share

  36. LEVY ME, Greenberg AE, Hart R, Powers Happ L, et al
    High burden of metabolic comorbidities in a citywide cohort of HIV outpatients: evolving health care needs of people aging with HIV in Washington, DC.
    HIV Med. 2017 May 15. doi: 10.1111/hiv.12516.
    >> Share

  37. BOMMART S, Cournil A, Eymard-Duvernay S, Raffi F, et al
    Smoking-associated morbidities on computed tomography lung cancer screens in HIV-infected smokers.
    HIV Med. 2017 May 15. doi: 10.1111/hiv.12517.
    >> Share

    April 2017
  38. KOENIG HC, Mounzer K, Daughtridge GW, Sloan CE, et al
    Urine assay for tenofovir to monitor adherence in real time to tenofovir disoproxil fumarate/emtricitabine as pre-exposure prophylaxis.
    HIV Med. 2017 Apr 26. doi: 10.1111/hiv.12518.
    >> Share

  39. BRANNSTROM J, Sonnerborg A, Svedhem V, Neogi U, et al
    A high rate of HIV-1 acquisition post immigration among migrants in Sweden determined by a CD4 T-cell decline trajectory model.
    HIV Med. 2017 Apr 26. doi: 10.1111/hiv.12509.
    >> Share

  40. TODESCO E, Charpentier C, Bertine M, Wirden M, et al
    Disparities in HIV-1 transmitted drug resistance detected by ultradeep sequencing between men who have sex with men and heterosexual populations.
    HIV Med. 2017 Apr 26. doi: 10.1111/hiv.12508.
    >> Share

  41. MONNO L, Saracino A, Scudeller L, Santoro C, et al
    Reduced community viral load does not coincide with a reduction in the rate of new HIV diagnoses and recent infections: data from a region of southern Italy.
    HIV Med. 2017 Apr 26. doi: 10.1111/hiv.12515.
    >> Share

  42. GANTNER P, Cuzin L, Allavena C, Cabie A, et al
    Efficacy and safety of dolutegravir and rilpivirine dual therapy as a simplification strategy: a cohort study.
    HIV Med. 2017 Apr 26. doi: 10.1111/hiv.12506.
    >> Share

  43. NEGEDU O, Kim SH, Weston R, Naous N, et al
    Retrospective review of routine clinical patient experiences with dolutegravir; virological suppression, immunological recovery and adverse events.
    HIV Med. 2017 Apr 26. doi: 10.1111/hiv.12510.
    >> Share

  44. PATTERSON S, Jose S, Samji H, Cescon A, et al
    A tale of two countries: all-cause mortality among people living with HIV and receiving combination antiretroviral therapy in the UK and Canada.
    HIV Med. 2017 Apr 24. doi: 10.1111/hiv.12505.
    >> Share

  45. MARZEL A, Shilaih M, Turk T, Campbell NK, et al
    Mining for pairs: shared clinic visit dates identify steady HIV-positive partnerships.
    HIV Med. 2017 Apr 4. doi: 10.1111/hiv.12507.
    >> Share


  46. Abstracts of the 23rd Annual Conference of the British HIV Association (BHIVA), Liverpool, UK, 4-7 April 2017.
    HIV Med. 2017;18 Suppl 1:3-70.
    >> Share

    March 2017
  47. JAMIESON L, Evans D, Brennan AT, Moyo F, et al
    Changes in elevated cholesterol in the era of tenofovir in South Africa: risk factors, clinical management and outcomes.
    HIV Med. 2017 Mar 23. doi: 10.1111/hiv.12495.
    >> Share

  48. TI L, Dong H, Kerr T, Turje RB, et al
    The effect of engagement in an HIV/AIDS integrated health programme on plasma HIV-1 RNA suppression among HIV-positive people who use illicit drugs: a marginal structural modelling analysis.
    HIV Med. 2017 Mar 19. doi: 10.1111/hiv.12493.
    >> Share

  49. ERB S, Letang E, Glass TR, Natamatungiro A, et al
    Health care provider communication training in rural Tanzania empowers HIV-infected patients on antiretroviral therapy to discuss adherence problems.
    HIV Med. 2017 Mar 13. doi: 10.1111/hiv.12499.
    >> Share

  50. MONROE AK, Zhang L, Jacobson LP, Plankey MW, et al
    The association between physical activity and cognition in men with and without HIV infection.
    HIV Med. 2017 Mar 13. doi: 10.1111/hiv.12490.
    >> Share

  51. BROWN J, McGowan JA, Chouial H, Capocci S, et al
    Respiratory health status is impaired in UK HIV-positive adults with virologically suppressed HIV infection.
    HIV Med. 2017 Mar 13. doi: 10.1111/hiv.12497.
    >> Share

  52. SOCIAS ME, Ti L, Dong H, Shoveller J, et al
    High prevalence of willingness to use direct-acting antiviral-based regimens for hepatitis C virus (HCV) infection among HIV/HCV coinfected people who use drugs.
    HIV Med. 2017 Mar 13. doi: 10.1111/hiv.12501.
    >> Share

  53. GEBRESELASSIE HM, Kraus D, Fux CA, Haubitz S, et al
    Ethnicity predicts viral rebound after travel to the tropics in HIV-infected travelers to the tropics in the Swiss HIV Cohort Study.
    HIV Med. 2017 Mar 1. doi: 10.1111/hiv.12491.
    >> Share

  54. PAYNE B, Chadwick TJ, Blamire A, Anderson KN, et al
    Does efavirenz replacement improve neurological function in treated HIV infection?
    HIV Med. 2017 Mar 1. doi: 10.1111/hiv.12503.
    >> Share

  55. TRON L, Lert F, Spire B, Dray-Spira R, et al
    Levels and determinants of breast and cervical cancer screening uptake in HIV-infected women compared with the general population in France.
    HIV Med. 2017;18:181-195.
    >> Share

    February 2017
  56. MENA A, Meijide H, Rodriguez-Osorio I, Castro A, et al
    Liver-related mortality and hospitalizations attributable to chronic hepatitis C virus coinfection in persons living with HIV.
    HIV Med. 2017 Feb 23. doi: 10.1111/hiv.12502.
    >> Share

  57. WANG Z, Wu X, Lau J, Mo P, et al
    Prevalence of and factors associated with unprotected anal intercourse with regular and nonregular male sexual partners among newly diagnosed HIV-positive men who have sex with men in China.
    HIV Med. 2017 Feb 23. doi: 10.1111/hiv.12500.
    >> Share

  58. PUHR R, Petoumenos K, Youds D, Law MG, et al
    The impact of changes in HIV management guidelines on time to treatment initiation in Australia.
    HIV Med. 2017 Feb 22. doi: 10.1111/hiv.12504.
    >> Share

  59. RALLON N, Restrepo C, Vicario JL, Del Romero J, et al
    Human leucocyte antigen (HLA)-DQB1*03:02 and HLA-A*02:01 have opposite patterns in their effects on susceptibility to HIV infection.
    HIV Med. 2017 Feb 20. doi: 10.1111/hiv.12494.
    >> Share

  60. WILLIAMS C
    Response to Glinka et al. "Timing matters - influenza vaccination to HIV-infected patients".
    HIV Med. 2017 Feb 16. doi: 10.1111/hiv.12485.
    >> Share

  61. MANCINELLI S, Nielsen-Saines K, Germano P, Guidotti G, et al
    Who will be lost? Identifying patients at risk of loss to follow-up in Malawi. The DREAM Program Experience.
    HIV Med. 2017 Feb 2. doi: 10.1111/hiv.12492.
    >> Share

  62. GALLIEN S, Journot V, Loriot MA, Sauvageon H, et al
    Cytochrome 2B6 polymorphism and efavirenz-induced central nervous system symptoms : a substudy of the ANRS ALIZE trial.
    HIV Med. 2017 Feb 1. doi: 10.1111/hiv.12488.
    >> Share

    January 2017
  63. SERNA-OJEDA JC, Navas A, Graue-Hernandez EO
    Smaller needles, lower risks?: Occupational HIV risk for healthcare professionals.
    HIV Med. 2017 Jan 27. doi: 10.1111/hiv.12496.
    >> Share

  64. DESAI S, Nardone A, Hughes G, Delpech V, et al
    HIV incidence in an open national cohort of men who have sex with men attending sexually transmitted infection clinics in England.
    HIV Med. 2017 Jan 27. doi: 10.1111/hiv.12498.
    >> Share

  65. ELLIOT ER, Singh S, Tyebally S, Gedela K, et al
    Recreational drug use and chemsex among HIV-infected in-patients: a unique screening opportunity.
    HIV Med. 2017 Jan 24. doi: 10.1111/hiv.12487.
    >> Share

  66. CRESSWELL FV, Levett T
    Specialist care of older adults with HIV infection in the UK: a service evaluation.
    HIV Med. 2017 Jan 24. doi: 10.1111/hiv.12481.
    >> Share

  67. DREW RS, Rice B, Ruutel K, Delpech V, et al
    HIV continuum of care in Europe and Central Asia.
    HIV Med. 2017 Jan 24. doi: 10.1111/hiv.12480.
    >> Share

  68. YOUSSEF E, Cooper V, Nixon E, Vera JH, et al
    The management of comorbidities in older people living with HIV in England: a cross sectional survey.
    HIV Med. 2017 Jan 24. doi: 10.1111/hiv.12484.
    >> Share

  69. CALZA L, Colangeli V, Magistrelli E, Bussini L, et al
    Plasma trough concentrations of darunavir/ritonavir and raltegravir in older patients with HIV-1 infection.
    HIV Med. 2017 Jan 24. doi: 10.1111/hiv.12478.
    >> Share

  70. NUNEZ-TORRES R, Macias J, Rivero-Juarez A, Neukam K, et al
    Fat mass and obesity-associated gene variations are related to fatty liver disease in HIV-infected patients.
    HIV Med. 2017 Jan 24. doi: 10.1111/hiv.12489.
    >> Share

  71. GLINKA ER, Smith DM, Johns ST
    Now is the Time to Study the Timing of Influenza Vaccine.
    HIV Med. 2017 Jan 24. doi: 10.1111/hiv.12486.
    >> Share

  72. O'LAUGHLIN KN, Kasozi J, Rabideau DJ, Parker RA, et al
    The cascade of HIV care among refugees and nationals in Nakivale Refugee Settlement in Uganda.
    HIV Med. 2017 Jan 10. doi: 10.1111/hiv.12476.
    >> Share

  73. NOY M, Merika EE, Morar N, Nelson M, et al
    aSKINg advice-the need for specialist dermatologists in HIV units.
    HIV Med. 2017;18:64-65.
    >> Share

  74. MADGE S, Smith C, Warren-Gash C, Bayly J, et al
    Screening for intimate partner violence in a London HIV clinic: characteristics of those screening positive.
    HIV Med. 2017;18:66-68.
    >> Share

    December 2016
  75. SORIANO-ARANDES A, Noguera-Julian A, Fortuny C
    Impact of immigration on HIV mother-to-child transmission in Western Europe.
    HIV Med. 2016 Dec 30. doi: 10.1111/hiv.12482.
    >> Share

  76. POVEDA E, Hernandez-Quero J, Perez-Elias MJ, Ribas MA, et al
    Genotypic tropism testing of proviral DNA to guide maraviroc initiation in aviraemic subjects: 48-week analysis of results from the PROTEST study.
    HIV Med. 2016 Dec 30. doi: 10.1111/hiv.12479.
    >> Share

  77. HARRISON N, Poeppl W, Herkner H, Tillhof KD, et al
    Predictors for and coverage of influenza vaccination among HIV-positive patients: a cross-sectional survey.
    HIV Med. 2016 Dec 30. doi: 10.1111/hiv.12483.
    >> Share

  78. SEWELL J, Daskalopoulou M, Nakagawa F, Lampe FC, et al
    Accuracy of self-report of HIV viral load among people with HIV on antiretroviral treatment.
    HIV Med. 2016 Dec 22. doi: 10.1111/hiv.12477.
    >> Share

  79. KUMAR P, Lakshmi YS, Kondapi AK
    An oral formulation of efavirenz-loaded lactoferrin nanoparticles with improved biodistribution and pharmacokinetic profile.
    HIV Med. 2016 Dec 21. doi: 10.1111/hiv.12475.
    >> Share

  80. FLORIDIA M, Tamburrini E, Masuelli G, Martinelli P, et al
    Rate, correlates and outcomes of repeat pregnancy in HIV-infected women.
    HIV Med. 2016 Dec 21. doi: 10.1111/hiv.12473.
    >> Share

  81. CHADWICK DR, Hall C, Rae C, Rayment M, et al
    A feasibility study for a clinical decision support system prompting HIV testing.
    HIV Med. 2016 Dec 21. doi: 10.1111/hiv.12472.
    >> Share

  82. HENRIQUEZ-CAMACHO C, Villafuerte-Gutierrez P, Perez-Molina JA, Losa J, et al
    Opt-out screening strategy for HIV infection among patients attending emergency departments: systematic review and meta-analysis.
    HIV Med. 2016 Dec 21. doi: 10.1111/hiv.12474.
    >> Share

  83. JIN C, Cheng L, Hoxtermann S, Xie T, et al
    MicroRNA-155 is a biomarker of T-cell activation and immune dysfunction in HIV-1-infected patients.
    HIV Med. 2016 Dec 16. doi: 10.1111/hiv.12470.
    >> Share

  84. FRASER-TALIENTE T, Mackie NE, Kaye S, Nyirenda M, et al
    Off-licence use of once-daily maraviroc in children and adolescents with perinatally acquired HIV-1 infection.
    HIV Med. 2016 Dec 16. doi: 10.1111/hiv.12467.
    >> Share

    November 2016
  85. MACIAS J, Monge P, Mancebo M, Merchante N, et al
    High frequency of potential interactions between direct-acting antivirals and concomitant therapy in HIV/hepatitis C virus-coinfected patients in clinical practice.
    HIV Med. 2016 Nov 24. doi: 10.1111/hiv.12471.
    >> Share

  86. TOWNSEND CL, de Ruiter A, Peters H, Nelson-Piercy C, et al
    Pregnancies in older women living with HIV in the UK and Ireland.
    HIV Med. 2016 Nov 16. doi: 10.1111/hiv.12469.
    >> Share

  87. HOFFMANN C, Welz T, Sabranski M, Kolb M, et al
    Higher rates of neuropsychiatric adverse events leading to dolutegravir discontinuation in women and older patients.
    HIV Med. 2016 Nov 10. doi: 10.1111/hiv.12468.
    >> Share

  88. WEBEL AR, Sattar A, Funderburg NT, Kinley B, et al
    Alcohol and dietary factors associate with gut integrity and inflammation in HIV-infected adults.
    HIV Med. 2016 Nov 9. doi: 10.1111/hiv.12442.
    >> Share


  89. A note of thanks to referees for Volume 17, 2016.
    HIV Med. 2016;17:778-780.
    >> Share


  90. Erratum.
    HIV Med. 2016;17:781.
    >> Share

    October 2016
  91. UNDERWOOD J, De Francesco D, Post FA, Vera JH, et al
    Associations between cognitive impairment and patient-reported measures of physical/mental functioning in older people living with HIV.
    HIV Med. 2016 Oct 26. doi: 10.1111/hiv.12434.
    >> Share

  92. GRINT D, Tedaldi E, Peters L, Mocroft A, et al
    Hepatitis C virus (HCV) RNA profiles among chronic HIV/HCV-coinfected individuals in ESPRIT; spontaneous HCV RNA clearance observed in nine individuals.
    HIV Med. 2016 Oct 26. doi: 10.1111/hiv.12466.
    >> Share

  93. FERRAIOLI G
    The clinical value of the controlled attenuation parameter in the follow-up of HIV-infected patients.
    HIV Med. 2016 Oct 4. doi: 10.1111/hiv.12443.
    >> Share

  94. ST-JEAN M, Harrigan PR, Sereda P, Montaner J, et al
    An assessment of the relationship between the World Health Organization HIV drug resistance early warning indicators and HIV drug resistance acquisition.
    HIV Med. 2016 Oct 4. doi: 10.1111/hiv.12435.
    >> Share

  95. MODY N, Nixon E, Buckingham T, Churchill D, et al
    It's the quality that counts: audit of the quality of transfer information for patients moving their HIV care between units.
    HIV Med. 2016;17:708.
    >> Share

  96. RAFFI F, Esser S, Nunnari G, Perez-Valero I, et al
    Switching regimens in virologically suppressed HIV-1-infected patients: evidence base and rationale for integrase strand transfer inhibitor (INSTI)-containing regimens.
    HIV Med. 2016;17 Suppl 5:3-16.
    >> Share

    September 2016
  97. CANAN CE, Lau B, McCaul ME, Keruly J, et al
    Effect of alcohol consumption on all-cause and liver-related mortality among HIV-infected individuals.
    HIV Med. 2016 Sep 28. doi: 10.1111/hiv.12433.
    >> Share

  98. LENG CY, Low HC, Chua LL, Chong ML, et al
    Human papillomavirus 16 (HPV16) and HPV52 E6-specific immunity in HIV-infected adults on combination antiretroviral therapy.
    HIV Med. 2016 Sep 20. doi: 10.1111/hiv.12432.
    >> Share

  99. FEUILLET P, Lert F, Tron L, Aubriere C, et al
    Prevalence of and factors associated with depression among people living with HIV in France.
    HIV Med. 2016 Sep 14. doi: 10.1111/hiv.12438.
    >> Share

  100. JUDD A, Lodwick R, Noguera-Julian A, Gibb DM, et al
    Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in Europe.
    HIV Med. 2016 Sep 14. doi: 10.1111/hiv.12411.
    >> Share

  101. BOUTELOUP V, Sabin C, Mocroft A, Gras L, et al
    Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naive patients.
    HIV Med. 2016 Sep 14. doi: 10.1111/hiv.12389.
    >> Share

  102. ZHONG F, Tang W, Cheng W, Lin P, et al
    Acceptability and feasibility of a social entrepreneurship testing model to promote HIV self-testing and linkage to care among men who have sex with men.
    HIV Med. 2016 Sep 7. doi: 10.1111/hiv.12437.
    >> Share

  103. MODY N, Perry N, Richardson D, Barbour L, et al
    Routine HIV testing in acute hospital admissions.
    HIV Med. 2016;17:634.
    >> Share

    August 2016
  104. TEERAANANCHAI S, Kerr SJ, Amin J, Ruxrungtham K, et al
    Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis.
    HIV Med. 2016 Aug 31. doi: 10.1111/hiv.12421.
    >> Share

  105. KOWALSKA JD, Oprea C, de Witt S, Pozniak A, et al
    Euroguidelines in Central and Eastern Europe (ECEE) conference and the Warsaw Declaration - a comprehensive meeting report.
    HIV Med. 2016 Aug 24. doi: 10.1111/hiv.12436.
    >> Share

  106. NADEL J, Holloway CJ
    Screening and risk assessment for coronary artery disease in HIV infection: an unmet need.
    HIV Med. 2016 Aug 24. doi: 10.1111/hiv.12422.
    >> Share

  107. ZHANG X, Tang W, Li Y, Mahapatra T, et al
    The HIV/AIDS epidemic among young people in China between 2005 and 2012: results of a spatial temporal analysis.
    HIV Med. 2016 Aug 24. doi: 10.1111/hiv.12408.
    >> Share

  108. GISSLEN M, Svedhem V, Lindborg L, Flamholc L, et al
    Sweden, the first country to achieve the Joint United Nations Programme on HIV/AIDS (UNAIDS)/World Health Organization (WHO) 90-90-90 continuum of HIV care targets.
    HIV Med. 2016 Aug 18. doi: 10.1111/hiv.12431.
    >> Share

  109. LORD E, Stockdale AJ, Malek R, Rae C, et al
    Evaluation of HIV testing recommendations in specialty guidelines for the management of HIV indicator conditions.
    HIV Med. 2016 Aug 18. doi: 10.1111/hiv.12430.
    >> Share

  110. HOWARTH AR, Burns FM, Apea V, Jose S, et al
    Development and application of a new measure of engagement in out-patient HIV care.
    HIV Med. 2016 Aug 18. doi: 10.1111/hiv.12427.
    >> Share

  111. KHADEMI N, Reshadat S, Zangeneh A, Saeidi S, et al
    A comparative study of the spatial distribution of HIV prevalence in the metropolis of Kermanshah, Iran, in 1996-2014 using geographical information systems.
    HIV Med. 2016 Aug 18. doi: 10.1111/hiv.12416.
    >> Share

  112. SILVA-PINTO A, Costa A, Serrao R, Sarmento A, et al
    Ischaemic stroke in HIV-infected patients: a case-control study.
    HIV Med. 2016 Aug 18. doi: 10.1111/hiv.12415.
    >> Share

  113. FLOWERS P, Riddell J, Park C, Ahmed B, et al
    Preparedness for use of the rapid result HIV self-test by gay men and other men who have sex with men (MSM): a mixed methods exploratory study among MSM and those involved in HIV prevention and care.
    HIV Med. 2016 Aug 5. doi: 10.1111/hiv.12420.
    >> Share

  114. DO TC, Boettiger D, Law M, Pujari S, et al
    Smoking and projected cardiovascular risk in an HIV-positive Asian regional cohort.
    HIV Med. 2016;17:542-9.
    >> Share

  115. TOMINSKI D, Katchanov J, Driesch D, Daley MB, et al
    The late-presenting HIV-infected patient 30 years after the introduction of HIV testing: spectrum of opportunistic diseases and missed opportunities for early diagnosis.
    HIV Med. 2016 Aug 1. doi: 10.1111/hiv.12403.
    >> Share

  116. LIN SY, Lachowsky NJ, Hull M, Rich A, et al
    Awareness and use of nonoccupational post-exposure prophylaxis among men who have sex with men in Vancouver, Canada.
    HIV Med. 2016 Aug 1. doi: 10.1111/hiv.12369.
    >> Share

  117. MILAZZO L, Lai A, Calvi E, Ronzi P, et al
    Direct-acting antivirals in hepatitis C virus (HCV)-infected and HCV/HIV-coinfected patients: real-life safety and efficacy.
    HIV Med. 2016 Aug 1. doi: 10.1111/hiv.12429.
    >> Share

  118. KRIKKE M, Arends JE, Van Lelyveld S, Hoepelman A, et al
    Greater carotid intima media thickness at a younger age in HIV-infected patients compared with reference values for an uninfected cohort.
    HIV Med. 2016 Aug 1. doi: 10.1111/hiv.12428.
    >> Share

  119. ROJAS CASTRO D, Quatremere G, Sagaon-Teyssier L, Le Gall JM, et al
    Informal pre-exposure prophylaxis use in France: results from the Flash PrEP survey (2014).
    HIV Med. 2016 Aug 1. doi: 10.1111/hiv.12419.
    >> Share

  120. SUDJARITRUK T, Bunupuradah T, Aurpibul L, Kosalaraksa P, et al
    Adverse bone health and abnormal bone turnover among perinatally HIV-infected Asian adolescents with virological suppression.
    HIV Med. 2016 Aug 1. doi: 10.1111/hiv.12418.
    >> Share

  121. IMAZ A, Niubo J, Kashuba AD, Ferrer E, et al
    Elvitegravir concentrations in seminal plasma in HIV-1-infected men.
    HIV Med. 2016 Aug 1. doi: 10.1111/hiv.12417.
    >> Share

  122. TOSTEVIN A, White E, Dunn D, Croxford S, et al
    Recent trends and patterns in HIV-1 transmitted drug resistance in the United Kingdom.
    HIV Med. 2016 Aug 1. doi: 10.1111/hiv.12414.
    >> Share

  123. TEIRA R, Vidal F, Munoz-Sanchez P, Geijo P, et al
    Very low level viraemia and risk of virological failure in treated HIV-1-infected patients.
    HIV Med. 2016 Aug 1. doi: 10.1111/hiv.12413.
    >> Share

  124. FRENCH CE, Thorne C, Byrne L, Cortina-Borja M, et al
    Presentation for care and antenatal management of HIV in the UK, 2009-2014.
    HIV Med. 2016 Aug 1. doi: 10.1111/hiv.12410.
    >> Share

  125. CHURCHILL D, Waters L, Ahmed N, Angus B, et al
    British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015.
    HIV Med. 2016;17 Suppl 4:s2-s104.
    >> Share

  126. GERETTI AM, Brook G, Cameron C, Chadwick D, et al
    British HIV Association Guidelines on the Use of Vaccines in HIV-Positive Adults 2015.
    HIV Med. 2016;17 Suppl 3:s2-s81.
    >> Share

    July 2016
  127. MCGOWAN JA, Sherr L, Rodger AJ, Fisher M, et al
    Age, time living with diagnosed HIV infection, and self-rated health.
    HIV Med. 2016 Jul 7. doi: 10.1111/hiv.12398.
    >> Share

  128. KESSELRING S, Cescon A, Colley G, Osborne C, et al
    Quality of initial HIV care in Canada: extension of a composite programmatic assessment tool for HIV therapy.
    HIV Med. 2016 Jul 6. doi: 10.1111/hiv.12409.
    >> Share

  129. FOSTER C, Bamford A, Turkova A, Welch S, et al
    Paediatric European Network for Treatment of AIDS Treatment Guideline 2016 update: antiretroviral therapy recommended for all children living with HIV.
    HIV Med. 2016 Jul 6. doi: 10.1111/hiv.12399.
    >> Share

  130. POST FA, Yombi JC, Hougardy JM
    Monitoring of kidney function in older people living with HIV.
    HIV Med. 2016 Jul 6. doi: 10.1111/hiv.12396.
    >> Share

  131. MUSSO CG, Belloso WH
    Monitoring of kidney function in elderly HIV-positive patients.
    HIV Med. 2016 Jul 6. doi: 10.1111/hiv.12395.
    >> Share

    June 2016
  132. HERNANDEZ AV, Thota P, Pellegrino D, Pasupuleti V, et al
    A systematic review and meta-analysis of the relative efficacy and safety of treatment regimens for HIV-associated cerebral toxoplasmosis: is trimethoprim-sulfamethoxazole a real option?
    HIV Med. 2016 Jun 28. doi: 10.1111/hiv.12402.
    >> Share

  133. ROSSOUW TM, Nieuwoudt M, Manasa J, Malherbe G, et al
    HIV drug resistance levels in adults failing first-line antiretroviral therapy in an urban and a rural setting in South Africa.
    HIV Med. 2016 Jun 28. doi: 10.1111/hiv.12400.
    >> Share

  134. MYER L, Phillips TK, McIntyre JA, Hsiao NY, et al
    HIV viraemia and mother-to-child transmission risk after antiretroviral therapy initiation in pregnancy in Cape Town, South Africa.
    HIV Med. 2016 Jun 28. doi: 10.1111/hiv.12397.
    >> Share

  135. ARMENIA D, Di Carlo D, Maffongelli G, Borghi V, et al
    Virological response and resistance profile in HIV-1-infected patients starting darunavir-containing regimens.
    HIV Med. 2016 Jun 28. doi: 10.1111/hiv.12388.
    >> Share

  136. LI M, Foli Y, Liu Z, Wang G, et al
    High frequency of mitochondrial DNA mutations in HIV-infected treatment-experienced individuals.
    HIV Med. 2016 Jun 22. doi: 10.1111/hiv.12390.
    >> Share

  137. GIRARD PM, Antinori A, Arribas JR, Ripamonti D, et al
    Week 96 efficacy and safety of darunavir/ritonavir monotherapy vs. darunavir/ritonavir with two nucleoside reverse transcriptase inhibitors in the PROTEA trial.
    HIV Med. 2016 Jun 9. doi: 10.1111/hiv.12386.
    >> Share

  138. CHEUNG CC, Ding E, Sereda P, Yip B, et al
    Reductions in all-cause and cause-specific mortality among HIV-infected individuals receiving antiretroviral therapy in British Columbia, Canada: 2001-2012.
    HIV Med. 2016 Jun 9. doi: 10.1111/hiv.12379.
    >> Share

  139. SANCHEZ-GONZALEZ G
    The cost-effectiveness of treating triple coinfection with HIV, tuberculosis and hepatitis C virus.
    HIV Med. 2016 Jun 9. doi: 10.1111/hiv.12372.
    >> Share

  140. VIDELA S, Sirera G, Ornelas A, Pinol M, et al
    Incidence of squamous intraepithelial lesions in the anal canal of HIV-infected men with normal cytology, up to 8 years of follow-up.
    HIV Med. 2016;17:479-81.
    >> Share

    May 2016
  141. CRAUWELS HM, Kakuda TN, Ryan B, Zorrilla C, et al
    Pharmacokinetics of once-daily darunavir/ritonavir in HIV-1-infected pregnant women.
    HIV Med. 2016 May 17. doi: 10.1111/hiv.12366.
    >> Share

  142. SHMAGEL KV, Saidakova EV, Shmagel NG, Korolevskaya LB, et al
    Systemic inflammation and liver damage in HIV/hepatitis C virus coinfection.
    HIV Med. 2016 May 17. doi: 10.1111/hiv.12357.
    >> Share

  143. MICHEL L, Lions C, Winnock M, Lang JP, et al
    Psychiatric and substance use disorders in HIV/hepatitis C virus (HCV)-coinfected patients: does HCV clearance matter? [Agence Nationale de Recherche sur le SIDA et les Hepatites Virales (ANRS) HEPAVIH CO13 cohort].
    HIV Med. 2016 May 17. doi: 10.1111/hiv.12382.
    >> Share

  144. RODKJAER L, Gabel C, Laursen T, Slot M, et al
    Simple and practical screening approach to identify HIV-infected individuals with depression or at risk of developing depression.
    HIV Med. 2016 May 17. doi: 10.1111/hiv.12381.
    >> Share

  145. SELLIER P, Ostertag A, Collet C, Trout H, et al
    Disrupted trabecular bone micro-architecture in middle-aged male HIV-infected treated patients.
    HIV Med. 2016 May 17. doi: 10.1111/hiv.12380.
    >> Share

  146. EDELMAN EJ, Gordon KS, Tate JP, Becker WC, et al
    The impact of prescribed opioids on CD4 cell count recovery among HIV-infected patients newly initiating antiretroviral therapy.
    HIV Med. 2016 May 17. doi: 10.1111/hiv.12377.
    >> Share

  147. SIMMONS R, Kall M, Collins S, Cairns G, et al
    A global survey of HIV-positive people's attitudes towards cure research.
    HIV Med. 2016 May 11. doi: 10.1111/hiv.12391.
    >> Share

  148. FATKENHEUER G, Jessen H, Stoehr A, Jung N, et al
    PEPDar: A randomized prospective noninferiority study of ritonavir-boosted darunavir for HIV post-exposure prophylaxis.
    HIV Med. 2016 May 11. doi: 10.1111/hiv.12363.
    >> Share

  149. PASTORI D, Esposito A, Carnevale R, Bartimoccia S, et al
    Short-term in vivo modifications of platelet NADPH oxidase 2 (NOX2) and prostaglandin F in HIV-1 patients on abacavir-based therapies.
    HIV Med. 2016 May 10. doi: 10.1111/hiv.12383.
    >> Share

  150. MUTIMURA E, Shi Q, Hoover DR, Anastos K, et al
    Bone quality assessed using quantitative ultrasound at the distal radius does not differ in antiretroviral therapy-naive HIV-positive and HIV-negative Rwandan women.
    HIV Med. 2016 May 10. doi: 10.1111/hiv.12376.
    >> Share

    September 2015
  151. ROUGEMONT M, Nchotu Ngang P, Stoll B, Delhumeau C, et al
    Safety of zidovudine dose reduction in treatment-naive HIV infected patients. A randomized controlled study (MiniZID).
    HIV Med. 2015 Sep 10. doi: 10.1111/hiv.12303.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016